Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Khanduja Di

Cruces University Hospital-Biocruces Health Research Institute, Barakaldo, Spain
Publications

Review of Infliximab Therapy in Chronic Inflammatory Diseases: Mechanisms and Clinical Outcomes

Infliximab, a chimeric monoclonal antibody targeting tumor necrosis factor-alpha (TNF-α), has revolutionized the treatment landscape of chronic inflammatory diseases. This review comprehensively explores the mechanisms of action, therapeutic indications, and clinical outcomes associated with Infliximab therapy across various conditions.... Read More»

Khanduja Di

: J Pulm Res Dis 2024

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Relevant Topics
Top